Class Action Lawsuit Filed Against Walgreens Boots Alliance, Inc.

Bronstein, Gewirtz & Grossman, LLC Notifies Investors

NEW YORK CITY, NY / ACCESSWIRE / August 29, 2024

Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Walgreens Boots Alliance, Inc. (“Walgreens” or “the Company”) (NASDAQ:WBA) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Walgreens securities between October 12, 2023, and June 26, 2024, inclusive (the “Class Period”).

The lawsuit alleges that Walgreens and its officers made false and/or misleading statements and/or failed to disclose that: (1) the Company’s financial statements were not accurate due to improper accounting and other improprieties; (2) the Company failed to maintain adequate internal controls; and (3) as a result, Walgreens’ public statements were materially false and misleading at all relevant times.

Investors who purchased Walgreens securities during the Class Period may be able to seek compensation for their losses. If you are a shareholder of Walgreens and would like more information about the lawsuit, please contact Bronstein, Gewirtz & Grossman, LLC.

How this Lawsuit May Affect You

If you are a shareholder of Walgreens who purchased securities during the Class Period, you may be eligible to participate in the class action lawsuit and seek compensation for any losses incurred. It is important to consult with legal counsel to determine the best course of action for your individual situation.

How this Lawsuit May Affect the World

The outcome of this lawsuit against Walgreens Boots Alliance, Inc. could potentially set a precedent for how companies are held accountable for alleged violations of federal securities laws. If successful, this case may lead to increased transparency and accountability within the pharmaceutical industry, ultimately benefiting investors and consumers alike.

Conclusion

As the class action lawsuit against Walgreens progresses, investors and stakeholders should stay informed about developments in the case and consider their options for potential recovery. Transparency and accountability in the financial markets are essential for maintaining trust and integrity, and this lawsuit serves as a reminder of the importance of upholding these principles.